We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Ovid Therapeutics Inc | NASDAQ:OVID | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.02 | 0.60% | 3.34 | 3.32 | 3.34 | 3.34 | 3.32 | 3.33 | 816 | 14:54:53 |
Delaware | 001-38085 | 46-5270895 | ||||||
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||
441 Ninth Avenue, 14th Floor New York, New York | 10001 | |||||||
(Address of Principal Executive Offices) | (Zip Code) |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Common Stock, par value $0.001 per share | OVID | The Nasdaq Stock Market LLC |
Exhibit No. | Description | |||||||
99.1 | Press Release, dated November 8, 2022 | |||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
OVID THERAPEUTICS INC. | ||||||||
By: | /s/ Thomas M. Perone | |||||||
Thomas M. Perone | ||||||||
General Counsel & Corporate Secretary |
1 Year Ovid Therapeutics Chart |
1 Month Ovid Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions